Renal insufficiency as an independent predictor of mortality among women with heart failure

被引:74
作者
Bibbins-Domingo, K
Lin, F
Vittinghof, E
Barrett-Connor, E
Grady, D
Shlipak, MG
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA
[4] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.jacc.2004.07.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to explore the association between renal insufficiency and mortality among women with heart failure (HF) and to evaluate this risk by the presence of preserved or depressed systolic function. BACKGROUND Although HF is common in older women, little is known about their risk factors for mortality. METHODS This prospective cohort study retrospectively analyzed data from the Heart and Estrogen/ progestin Replacement Study (HERS). Of the 2,763 women in HERS, 702 had HF. Renal function was categorized as creatinine clearance (CrCl) >60 ml/min, 40 to 60 ml/min, and <40 ml/min. We used proportional hazards models to evaluate the association between renal insufficiency and mortality. RESULTS Over a mean 5.8 years, 228 women with HF died (32%). Renal insufficiency was strongly associated with mortality, even after adjustment for co-morbid conditions, systolic function, and medications (adjusted hazard ratio [HR] 1.53, 95% confidence interval [CI] 1.09 to 2.16 for CrCl 40 to 60 ml/min; adjusted HR 2.40, 95% CI 1.60 to 3.62 for CrCl <40 ml/min). Preserved or depressed systolic function did not modify the association between renal insufficiency and mortality risk, but the use of angiotensin-converting enzyme (ACE) inhibitors did modify this risk (ACE users: adjusted HR = 0.9, 95% CI 0.6 to 1.6; ACE nonusers: adjusted HR 2.1, 95% CI 1.3 to 3.2; p = 0.02 for interaction). Compared with other risk factors for mortality, renal insufficiency had the highest population attributable risk (27%). CONCLUSIONS Renal insufficiency was a major predictor of mortality among women with HF and preserved or depressed systolic function. This risk was attenuated by the use of ACE inhibitors. (C) 2004 by the American College of Cardiology Foundation.
引用
收藏
页码:1593 / 1600
页数:8
相关论文
共 28 条
  • [1] Chronic heart failure in the very elderly: Clinical status, survival, and prognostic factors in 188 patients more than 70 years old
    Cicoira, M
    Davos, CH
    Florea, V
    Shamim, W
    Doehner, W
    Coats, AJS
    Anker, SD
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (01) : 174 - 180
  • [2] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [3] The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction
    Dries, DL
    Exner, DV
    Domanski, MJ
    Greenberg, B
    Stevenson, LW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) : 681 - 689
  • [4] FLEISS JL, 1983, STAT METHODS RATES P
  • [5] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [6] The prognostic importance of different definitions of worsening renal function in congestive heart failure
    Gottlieb, SS
    Abraham, W
    Butler, J
    Forman, DE
    Loh, E
    Massie, BM
    O'Connor, CM
    Rich, MW
    Stevenson, LW
    Young, J
    Krumholz, HM
    [J]. JOURNAL OF CARDIAC FAILURE, 2002, 8 (03) : 136 - 141
  • [7] Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II)
    Grady, D
    Herrington, D
    Bittner, V
    Blumenthal, R
    Davidson, M
    Hlatky, M
    Hsia, J
    Hulley, S
    Herd, A
    Khan, S
    Newby, LK
    Waters, D
    Vittinghoff, E
    Wenger, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01): : 49 - 57
  • [8] Heart and Estrogen/progestin Replacement Study (HERS): Design, methods, and baseline characteristics
    Grady, D
    Applegate, W
    Bush, T
    Furberg, C
    Riggs, B
    Hulley, SB
    [J]. CONTROLLED CLINICAL TRIALS, 1998, 19 (04): : 314 - 335
  • [9] CONGESTIVE-HEART-FAILURE IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, PROGNOSIS AND RISK-FACTORS
    HARNETT, JD
    FOLEY, RN
    KENT, GM
    BARRE, PE
    MURRAY, D
    PARFREY, PS
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (03) : 884 - 890
  • [10] Representation of the elderly, women, and minorities in heart failure clinical trials
    Heiat, A
    Gross, CP
    Krumholz, HM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) : 1682 - 1688